- 2024-08-20 01:43抑制剂1-NM-PP1|1-NM-PP1|221244-14-0|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:43抑制剂1-EBIO|1-EBIO|10045-45-1|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 01:43抑制剂1-EBIO|1-EBIO|10045-45-1|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:43抑制剂1-EBIO|1-EBIO|10045-45-1|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:43抑制剂1-Linoleoyl Glycerol|1-Linoleoyl Glycerol|2277-28-3|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 01:43抑制剂12-O-Methylcarnosic acid|12-O-Methylcarnosic acid|62201-71-2|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:43抑制剂12-O-Methylcarnosic acid|12-O-Methylcarnosic acid|62201-71-2|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:43抑制剂1-BCP|1-BCP|34023-62-6|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:43抑制剂1,2-Dilauroyl-sn-glycero-3-phosphocholine|1,2-Dilauroyl-sn-glycero-3-phosphocholine|18194-25-7|Ad
- 2024-08-20 01:43抑制剂1,2-Dilauroyl-sn-glycero-3-phosphocholine|1,2-Dilauroyl-sn-glycero-3-phosphocholine|18194-25-7|Ad
- 2024-08-20 01:43抑制剂12-O-Methylcarnosic acid|12-O-Methylcarnosic acid|62201-71-2|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 01:43抑制剂[11C]MP 10|[11C]MP 10|1292799-56-4|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:43抑制剂1,2-Dilauroyl-sn-glycero-3-phosphocholine|1,2-Dilauroyl-sn-glycero-3-phosphocholine|18194-25-7|Ad
- 2024-08-20 01:43抑制剂[11C]MP 10|[11C]MP 10|1292799-56-4|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 01:43抑制剂[11C]MP 10|[11C]MP 10|1292799-56-4|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:43抑制剂(Z)-Orantinib|(Z)-Orantinib|210644-62-5|Adamas life|≥98%（以实测数值为准）|BR|500mg
- 2024-08-20 01:43抑制剂(Z)-Akuammidine|(Z)-Akuammidine|113973-31-2|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:43抑制剂(Z)-Akuammidine|(Z)-Akuammidine|113973-31-2|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:43抑制剂(Z)-Orantinib|(Z)-Orantinib|210644-62-5|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 01:43抑制剂(Z)-Orantinib|(Z)-Orantinib|210644-62-5|Adamas life|≥98%（以实测数值为准）|BR|25mg
